Stephen P. Mawer Sells 3,655 Shares of Calumet Specialty Products Partners, L.P. (NASDAQ:CLMT) Stock

Calumet Specialty Products Partners, L.P. (NASDAQ:CLMT) Director Stephen P. Mawer sold 3,655 shares of the firm’s stock in a transaction that occurred on Monday, March 24th. The shares were sold at an average price of $12.88, for a total transaction of $47,076.40. Following the completion of the sale, the director now directly owns 287,307 shares in the company, valued at approximately $3,700,514.16. This trade represents a 1.26 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Calumet Specialty Products Partners Price Performance

Shares of CLMT stock remained flat at $12.23 during mid-day trading on Wednesday. The company’s stock had a trading volume of 680,962 shares, compared to its average volume of 702,676. Calumet Specialty Products Partners, L.P. has a 12 month low of $9.97 and a 12 month high of $25.29. The company has a market capitalization of $1.05 billion, a PE ratio of -4.43 and a beta of 1.88. The firm’s 50-day moving average price is $15.05 and its two-hundred day moving average price is $18.55.

Calumet Specialty Products Partners (NASDAQ:CLMT) last released its quarterly earnings results on Friday, February 28th. The oil and gas company reported ($0.47) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($1.06) by $0.59. The firm had revenue of $949.50 million for the quarter, compared to analysts’ expectations of $921.76 million. During the same quarter in the prior year, the business earned ($0.59) EPS. The company’s quarterly revenue was down 2.8% compared to the same quarter last year. As a group, analysts anticipate that Calumet Specialty Products Partners, L.P. will post -3.02 earnings per share for the current year.

Analyst Upgrades and Downgrades

A number of equities research analysts have commented on the stock. Wells Fargo & Company dropped their price objective on shares of Calumet Specialty Products Partners from $29.00 to $28.00 and set an “overweight” rating on the stock in a research report on Wednesday, March 5th. HC Wainwright restated a “buy” rating and issued a $33.00 price target on shares of Calumet Specialty Products Partners in a research note on Monday, March 3rd. TD Cowen cut Calumet Specialty Products Partners from a “buy” rating to a “hold” rating and lowered their price objective for the stock from $26.00 to $16.00 in a research report on Tuesday, March 4th. Finally, UBS Group upgraded Calumet Specialty Products Partners from a “sell” rating to a “neutral” rating and dropped their price objective for the company from $15.00 to $12.00 in a report on Monday, March 17th. One analyst has rated the stock with a sell rating, two have given a hold rating and three have issued a buy rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Hold” and an average target price of $20.80.

Calumet Specialty Products Partners Company Profile

Calumet, Inc engages in the manufacturing, formulating, and marketing of a diversified slate of specialty branded products and renewable fuels to customers across a broad range of consumer-facing and industrial markets. It operates through the following segments: Specialty Products & Solutions, Performance Brands, Montana/Renewables, and Corporate.